"La Fundació Puigvert és un Hospital Universitari especialitzat en Urologia, Nefrologia, Andrologia i Reproducció Assistida. Constituida al 1961 a Barcelona, és un referent en les seves especialitats tant a nivell nacional com internacional."

During the past decade, Fundació Puigvert conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 6 clinical trials were completed, i.e. on average, 15.8% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 4 clinical trials were completed. i.e. 26.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundació Puigvert" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Fundacio Puigvert" with 5 trials sponsored, "Bayer" with 2 trials sponsored, "Devicare S.L." with 2 trials sponsored and "Ferring Pharmaceuticals" with 2 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundació Puigvert" #1 collaborator was "Clever Instruments S.L." with 2 trials as a collaborator, "Effice Servicios Para la Investigacion S.L." with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Analysis and Research Network, S.L" with 1 trials as a collaborator and "Axonal-Biostatem" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Fundació Puigvert" are "Urinary Bladder Neoplasms" (7 trials), "Prostate Cancer" (4 trials), "Autosomal Dominant Polycystic Kidney Disease" (3 trials), "ADPKD" (2 trials) and "Chronic Renal Failure" (2 trials). Many other conditions were trialed in "Fundació Puigvert" in a lesser frequency.

Most popular intervention types in "Fundació Puigvert" are "Drug" (34 trials), "Other" (8 trials), "Diagnostic Test" (6 trials), "Procedure" (6 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "TAR-200" (4 trials), "Cetrelimab" (3 trials), "Atrasentan" (2 trials) and "Degarelix" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fundació Puigvert" are 48 trials for "All" genders, 6 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Fundació Puigvert". 2 are not yet recruiting, 11 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Fundació Puigvert, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Fundació Puigvert, 3 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 6 trials that are defined as “Not Applicable".